Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
Bristol-Myers Squibb
259 followers
Astellas Pharma
42 followers
NYU Langone Health
26 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
277 followers
Navitus Health
4 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies